We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.


16 May 2018 By Robert Cyran

The animal-health giant will on the face of it only get a 2 pct return on investment from buying diagnostics firm Abaxis. It’s betting more owners globally will shell out big bucks on their pets – and so fluff up earnings. If not, $40 bln Zoetis will be nursing a dog of a deal.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)